AwardedCzechiaGoodsCZK 100,551,000
Selektivní Imunosupresiva - Vedolizumab_VII.
- Published
- Published 13 February 2026
- Deadline
- Closed 17 March 2026
Overview
Předmětem veřejné zakázky jsou dodávky léčivých přípravků pro intravenózní (i.v.) a subkutánní podání (s.c.) s obsahem monoklonální protilátky vedolizumab (ATC skupina L04AG05) pro léčbu pacientů ve schválených indikacích dle SPC platného ke dni podání nabídky.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 100,551,000
- Procedure
- Open
- Published
- 13 February 2026
- Deadline
- Closed
Immunosuppressive agents
Award outcome
- Awarded value
- CZK 100,550,882
- Award date
- 20 March 2026
- Contract period
- — → 27 February 2030
- Takeda Pharmaceuticals Czech Republic s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 April 2026
Contract Notice
13 February 2026
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.